| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Blood transfusion is an integral part of the supportive care for
patients with sickle cell disease (SCD) and thalassaemia. The hazard of
red cell alloimmunization, however, is one of the main complications of
Materials and Methods
|Table1. Type and frequency of antibodies identified in Thalassemia and SCD patients|
|Figure 1. Number (%) of specific antibodies in SCD (Figure 1a) & Homozygous Thalassaemia Major patients (Figure 1b).|
AcknowledgementWe wish to thank the hospital administration for the use of hospital material for this study.